Delivery Order SPE2DB22D1103-SPE2DB24FTPA5

Award Date 7/24/24
Potential Completion Date 7/25/24
Potential Value $2K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award, with ID SPE2DB20D2104|SPE2DB25FMFKZ, was issued by the Defense Logistics Agency (DLA) to the prime contractor Amerisourcebergen Drug Corp. The $4,365.84 firm fixed-price delivery order is for the supply of JANUVIA 100 MG TABLET 90S, a pharmaceutical product. The contract has an ultimate completion date of January 7, 2025. Amerisourcebergen Drug Corp is a major pharmaceutical distributor and healthcare solutions provider that plays a critical role in supplying medical...
This federal contract award was made by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $2,341.79 firm fixed-price delivery order is for the supply of JANUVIA 100 MG TABLET 90S, a pharmaceutical product. The contract has an ultimate completion date of May 14, 2024. This award is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) that Amerisourcebergen holds with the DLA Troop Support...
This federal contract award was issued by the Defense Logistics Agency (DLA) to the prime contractor Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $2,031.46 firm fixed-price delivery order is for the supply of JANUVIA 50 MG TABLET 90S, a pharmaceutical product. The contract has an ultimate completion date of July 11, 2023. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $15,025.29 firm fixed price delivery order is for the supply of JANUVIA 100 MG TABLET 90S, a pharmaceutical product. The contract has an ultimate completion date of November 29, 2023. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a...
This federal contract award, SPE2DB22D1041|SPE2DB24FUBN5, was issued by the Defense Logistics Agency (DLA) to the prime contractor Amerisourcebergen Drug Corp. The $3,328.87 firm-fixed-price delivery order is for the supply of JANUVIA 100 MG TABLET 90S, a pharmaceutical product. The contract has an ultimate completion date of May 20, 2024. Amerisourcebergen Drug Corp is a major pharmaceutical distributor and healthcare solutions provider that plays a critical role in supplying medical products...
This federal contract award from the Defense Logistics Agency (DLA) was issued to the prime contractor, Amerisourcebergen Drug Corp, for the delivery of JANUVIA 100 MG TABLET 90S. The $8,228.33 firm fixed price contract has a completion date of December 5, 2024. Amerisourcebergen Drug Corp is a large pharmaceutical distributor that provides a wide range of medical products and supplies to federal agencies, particularly to support military and veterans' healthcare programs. This award is a...
This federal contract award, with ID SPE2DB25D3018|SPE2DB25FUXJJ, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,674.81 firm fixed-price delivery order is for the supply of 4,568,062,473 units of the pharmaceutical product JANUVIA 25 MG TABLET 90S. The contract has an ultimate completion date of April 29, 2025 and is not designated as a set-aside. Amerisourcebergen Drug Corp holds a...
This federal contract award, with ID SPE2DB20D1050|SPE2DB25FH54X, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,347.16 firm fixed-price delivery order is for the supply of 4567617102 JANUVIA 100 MG TABLET 90S, a pharmaceutical product. The contract has an ultimate completion date of March 19, 2025. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC)...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,930.00 firm fixed-price delivery order is for the supply of JANUVIA 100 MG TABLET 90S, a pharmaceutical product. The contract has an ultimate completion date of October 25, 2024 and was awarded on October 24, 2024. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop...
This federal contract award, with ID SPE2DB20D2014|SPE2DB25FB76J, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,455.28 Firm Fixed Price delivery order is for the supply of Januvia 100 mg tablets, a medication used to treat diabetes. The contract has an ultimate completion date of April 29, 2025 and is not set aside for any specific business type. AmerisourceBergen Drug Corp holds a...
  • SPE2DB22D1103
    Indefinite Delivery Contract
  • SPE2DB22D1103-SPE2DB24FTPA5
    Delivery Order

This federal contract award, with ID SPE2DB22D1103|SPE2DB24FTPA5, was issued by the Defense Logistics Agency (DLA) to the prime contractor Amerisourcebergen Drug Corp. The $1,983.36 firm fixed-price delivery order is for the supply of JANUVIA 25 MG TABLET 90S, a pharmaceutical product. The contract has an ultimate completion date of July 25, 2024.

Amerisourcebergen Drug Corp is a major pharmaceutical distributor and healthcare solutions provider that plays a critical role in supplying medical products to federal government agencies, particularly the DLA Troop Support Medical. The company holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA, running through November 2026, which serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. This contract award appears to be a direct order under that larger IDC.

The contract does not have a set-aside designation, indicating open competition. No major subcontractors are mentioned in the information provided.

Generated 5/17/25, 10:06 AM